vimarsana.com

Latest Breaking News On - Americas committee - Page 17 : vimarsana.com

ACTRIMS 2023: Certain eye cells linked to MS-related changes | These cells may play key role in vision changes in MS, study finds

Certain eye cells specifically blood vessel and microglia cells exhibit high activity of genes that have been linked to MS, a study found.

San diegoUnited statesJohns hopkinsSamantha haoJohns hopkins universityAmericas committee for treatmentResearch in multiple sclerosisAmericas committeeMultiple sclerosisSingle cell transcriptomicsRetinal layer thicknesses

ACTRIMS 2023: Documentary offers hope for Black MS community | In interview, MS advocates highlight huge need for greater visibility

A new documentary, "MS in Black and African Americans," explores the experiences of Black patients in the U.S. living with multiple sclerosis.

United statesSan diegoSan diego state universitySophia woodsonMitzi joi williamsTyler campbellAmericas committee for treatmentPublic televisionNational multiple sclerosis societyJoi life wellness ms neurology centerNational african americansResearch in multiple sclerosisInventi media groupJoi williamsMultiple sclerosis newsAmericas committee

ACTRIMS 2023: Most patients on Briumvi show no MS activity after 6 months | Briumvi led to no MS activity in 80% of patients in ULTIMATE trials

More than 80% of MS patients on Briumvi in the ULTIMATE trials had no signs of disease activity after the first six months, data show.

United statesSan diegoEnrique alvarezPeiqing qianSwedish neuroscience instituteUniversity of coloradoAmericas committee for treatmentResearch in multiple sclerosisAmericas committeeMultiple sclerosisDisease activity with ublituximabParticipants with relapsing multiple sclerosis

ACTRIMS 2023: MS found to be less likely for HIV-positive people | HIV infection may protect against MS, especially in women: Study

People who are HIV-positive, including those given antiretroviral treatment, were found to be less likely to develop multiple sclerosis (MS).

San diegoUnited statesUnited kingdomElaine kingwellUniversity college londonInternational cohortAmericas committee for treatmentResearch in multiple sclerosisAmericas committeeMultiple sclerosisBritish columbia

ACTRIMS 2023: CNM-Au8 bound for Phase 3 testing after positive data | Multiple Sclerosis News Today

The upcoming global Phase 3 clinical trial will test CNM-Au8's effect on MS disease progression that occurs independently of relapse activity.

San diegoUnited statesMichael hotchkinBenjamin greenbergClene nanomedicineSouthwestern medical centerAmericas committee for treatmentResearch in multiple sclerosisMultiple sclerosis news todayAmericas committeeMultiple sclerosisMultiple sclerosis functional composite

vimarsana © 2020. All Rights Reserved.